Drug-excipient compatibility studies are an important part during the development of a new formulation. They ensure that no interaction occurs between drug and excipients that could affect the properties, stability, efficacy of the active ingredient. Thermal Analysis is used for rapid assessment of physicochemical interactions.
Generally, a drug product doesn´t only contain the API (Active Pharmaceutical Ingredient), i.e., the substance fighting the sickness or pain, but also excipients, i.e., substances selected to facilitate administration of the dosage form, modulate the release of the API and stabilize it against degradation.
Of course, the presence of the excipients must not affect the properties, stability, efficacy of the active ingredient. So-called drug-excipient compatibility studies are essential to reveal eventual interactions between the drug and excipients.
An interaction can be underscored using spectroscopic and microscopic techniques, but also thermal methods, particularly thermal analysis, and more specifically differential scanning calorimetry (DSC) and thermogravimetry (TG). These two methods play an important role in compatibility screening and are frequently employed for rapid assessment of physicochemical interactions.
Let’s have a look at the DSC curves of 2 substances that interact – or not. For that, you carry out a DSC measurement on each component as well as on the mixture of both components (50/50 weight).
Figure 1 displays the DSC curves of the API (active pharmaceutical ingredient) and excipient with melting peak.
A resulting DSC curve that shows no interaction between the API and excipient (figure 2) indicates that the excipient is recommended for the formulation using the API. In this case, there is a compatibility between the API and the excipient; the DSC curve will continue to show the melting peaks of the two substances unaltered at the same temperature.
The occurrence of a new peak in the mixture, the disappearance of a peak, or a change in melting peak (shape, position, or enthalpy) indicates that there is an interaction between the two components (figure 3). However, this doesn’t necessarily mean that the drug and excipient are not compatible. Additional investigations would have to be carried out with other techniques (X-ray, spectroscopy, chromatography, etc.) to confirm incompatibility.
An example of compatibility study on diclofenac is given here. It shows how fast and easy thermal analysis detects drug/excipient interactions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.